0001493152-21-023406.txt : 20210922 0001493152-21-023406.hdr.sgml : 20210922 20210922173459 ACCESSION NUMBER: 0001493152-21-023406 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210920 FILED AS OF DATE: 20210922 DATE AS OF CHANGE: 20210922 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Malley Brendan M. CENTRAL INDEX KEY: 0001884342 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15771 FILM NUMBER: 211270391 MAIL ADDRESS: STREET 1: 1330 AVENUE OF THE AMERICAS STREET 2: 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC. CENTRAL INDEX KEY: 0000318306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 830221517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 646-813-4701 MAIL ADDRESS: STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC DATE OF NAME CHANGE: 20140922 FORMER COMPANY: FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960209 FORMER COMPANY: FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 3 1 ownership.xml X0206 3 2021-09-20 0 0000318306 ABEONA THERAPEUTICS INC. ABEO 0001884342 O'Malley Brendan M. 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 0 1 0 0 SVP, General Counsel Common stock 137454 D Stock Option (right to buy) 1.15 2029-05-31 Common stock 55000 D Stock Option (right to buy) 1.15 2030-03-16 Common stock 50000 D Stock Option (right to buy) 2.34 2031-03-01 Common stock 100000 D Includes 130,113 shares of unvested restricted stock, which will vest on various dates between September 30, 2021 and March 1, 2025. The options vest 25% on May 31, 2020, and in 36 equal monthly installments thereafter. The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter. The options vest 25% on March 1, 2022, and in 36 equal monthly installments thereafter. /s/ Brendan O'Malley 2021-09-22